Kodiak Sciences is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases globally
Our ambition is to become a significant incumbent retinal development and commercialization franchise on a global basis
Our Mission
Kodiak aims to prevent and treat the leading causes of blindness in the developed world
Trailblazing science
Our creative and thoughtful foundation
"Go-to" medicines
Our Challenge to the status quo
singular focus in ophthalmology
our 24/7/365
OUR SCIENCE
We are developing disruptive products and platforms to prevent and treat the leading causes of blindness
We are committed to progressing and expanding our pipeline towards the prevention, treatment and, when possible, the cure of high-prevalence ophthalmology diseases
Working at Kodiak
We aspire to global leadership in ophthalmology through internal focus and by aggregating top talent, technologies, discoveries and ideas.
Some of the statements on this site are forward-looking. Such statements are inherently subject to known as well as unknown risks and uncertainties, including scientific, business, economic and financial factors and other factors that may cause actual results, performance or achievements of Kodiak Sciences to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements speak only as of the date they are posted to this website (unless an earlier date is indicated). Kodiak Sciences does not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Kodiak’s drug candidates are investigational compounds in development and have not received regulatory approval in any country.